AbstractA summary of the recently published efforts on tacrine derivatives as a renewed potential therapeutic approach for the treatment of Alzheimer’s disease is presented
Pursuing the widespread interest on multi-target drugs to combat Alzheimers disease (AD), a new seri...
Alzheimer’s disease (AD) remains an unmet medical need despite global efforts to identify drugs that...
Tacrine (1) was the first acetylcholinesterase inhibitor (AChEI) introduced in therapy for the treat...
AbstractA summary of the recently published efforts on tacrine derivatives as a renewed potential th...
To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) i...
A novel series of tacrine derivatives were designed and synthesized by combining caffeic acid (CA), ...
Herein we have reviewed our recent developments for the identification of new tacrine analogues for ...
Tacrine was the first drug to display beneficial effects on cognitive impairment of Alzheimer Diseas...
Alzheimer’s disease (AD) is a complex, neurodegenerative pathology showing, among others, high choli...
Master's thesis in Biological ChemistryWorld health organization estimates that nearly 9.9 million p...
The evaluation of the clinical effects of Tacrine has shown efficacy in delaying the deterioration o...
Based on a multitarget strategy, a series of novel tacrine–pyrimidone hybrids were identified for th...
The authors acknowledge the Portuguese Fundação para a Ciência e Tecnologia (FCT) for the project UI...
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available the...
Tacrine was the first drug to be approved for Alzheimer’s disease (AD) treatment, acting as a cholin...
Pursuing the widespread interest on multi-target drugs to combat Alzheimers disease (AD), a new seri...
Alzheimer’s disease (AD) remains an unmet medical need despite global efforts to identify drugs that...
Tacrine (1) was the first acetylcholinesterase inhibitor (AChEI) introduced in therapy for the treat...
AbstractA summary of the recently published efforts on tacrine derivatives as a renewed potential th...
To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) i...
A novel series of tacrine derivatives were designed and synthesized by combining caffeic acid (CA), ...
Herein we have reviewed our recent developments for the identification of new tacrine analogues for ...
Tacrine was the first drug to display beneficial effects on cognitive impairment of Alzheimer Diseas...
Alzheimer’s disease (AD) is a complex, neurodegenerative pathology showing, among others, high choli...
Master's thesis in Biological ChemistryWorld health organization estimates that nearly 9.9 million p...
The evaluation of the clinical effects of Tacrine has shown efficacy in delaying the deterioration o...
Based on a multitarget strategy, a series of novel tacrine–pyrimidone hybrids were identified for th...
The authors acknowledge the Portuguese Fundação para a Ciência e Tecnologia (FCT) for the project UI...
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available the...
Tacrine was the first drug to be approved for Alzheimer’s disease (AD) treatment, acting as a cholin...
Pursuing the widespread interest on multi-target drugs to combat Alzheimers disease (AD), a new seri...
Alzheimer’s disease (AD) remains an unmet medical need despite global efforts to identify drugs that...
Tacrine (1) was the first acetylcholinesterase inhibitor (AChEI) introduced in therapy for the treat...
DOI
Add to ORKG